These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29278273)

  • 1. Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A "structure-activity relationship" perspective.
    Bhattarai D; Xu X; Lee K
    Med Res Rev; 2018 Jul; 38(4):1404-1442. PubMed ID: 29278273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015).
    Ban HS; Uto Y; Won M; Nakamura H
    Expert Opin Ther Pat; 2016; 26(3):309-22. PubMed ID: 26882240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1 as a therapeutic target in cancer.
    Tang CM; Yu J
    J Gastroenterol Hepatol; 2013 Mar; 28(3):401-5. PubMed ID: 23173651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting hypoxia-inducible factor 1 for cancer therapy.
    Melillo G
    Mol Cancer Res; 2006 Sep; 4(9):601-5. PubMed ID: 16940159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress of hypoxia-inducible factor 1 inhibitors against tumors].
    Niu F; Li Y; Lai FF; Chen XG
    Yao Xue Xue Bao; 2014 Jun; 49(6):832-6. PubMed ID: 25212028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents.
    Wei J; Yang Y; Lu M; Lei Y; Xu L; Jiang Z; Xu X; Guo X; Zhang X; Sun H; You Q
    Mini Rev Med Chem; 2018; 18(4):296-309. PubMed ID: 27484627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noscapine inhibits hypoxia-mediated HIF-1alpha expression andangiogenesis in vitro: a novel function for an old drug.
    Newcomb EW; Lukyanov Y; Schnee T; Ali MA; Lan L; Zagzag D
    Int J Oncol; 2006 May; 28(5):1121-30. PubMed ID: 16596228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis.
    Yang T; Yao Q; Cao F; Liu Q; Liu B; Wang XH
    Int J Nanomedicine; 2016; 11():6679-6692. PubMed ID: 27994464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy.
    Yu T; Tang B; Sun X
    Yonsei Med J; 2017 May; 58(3):489-496. PubMed ID: 28332352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diacetoxyscirpenol as a new anticancer agent to target hypoxia-inducible factor 1.
    Choi YJ; Shin HW; Chun YS; Leutou AS; Son BW; Park JW
    Oncotarget; 2016 Sep; 7(38):62107-62122. PubMed ID: 27613833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF Inhibitors: Status of Current Clinical Development.
    Fallah J; Rini BI
    Curr Oncol Rep; 2019 Jan; 21(1):6. PubMed ID: 30671662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent agents targeting HIF-1α for cancer therapy.
    Hu Y; Liu J; Huang H
    J Cell Biochem; 2013 Mar; 114(3):498-509. PubMed ID: 22961911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of kresoxim-methyl analogues as novel inhibitors of hypoxia-inducible factor (HIF)-1 accumulation in cancer cells.
    Lee S; Kwon OS; Lee CS; Won M; Ban HS; Ra CS
    Bioorg Med Chem Lett; 2017 Jul; 27(13):3026-3029. PubMed ID: 28526370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.
    Li MY; Mi C; Wang KS; Wang Z; Zuo HX; Piao LX; Xu GH; Li X; Ma J; Jin X
    Chem Biol Interact; 2017 Aug; 274():58-67. PubMed ID: 28684144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel inhibitors targeting HIF-1α towards anticancer drug discovery.
    Yewalkar N; Deore V; Padgaonkar A; Manohar S; Sahu B; Kumar P; Jalota-Badhwar A; Joshi KS; Sharma S; Kumar S
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6426-9. PubMed ID: 20932758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Biological Evaluation of Manassantin Analogues for Hypoxia-Inducible Factor 1α Inhibition.
    Kwon DY; Lee HE; Weitzel DH; Park K; Lee SH; Lee CT; Stephenson TN; Park H; Fitzgerald MC; Chi JT; Mook RA; Dewhirst MW; Lee YM; Hong J
    J Med Chem; 2015 Oct; 58(19):7659-71. PubMed ID: 26394152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine Kinase-1 Involves the Inhibitory Action of HIF-1α by Chlorogenic Acid in Hypoxic DU145 Cells.
    Lee MS; Lee SO; Kim KR; Lee HJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28165392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.
    Lin D; Wu J
    World J Gastroenterol; 2015 Nov; 21(42):12171-8. PubMed ID: 26576101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of approved and investigational drugs that inhibit hypoxia-inducible factor-1 signaling.
    Hsu CW; Huang R; Khuc T; Shou D; Bullock J; Grooby S; Griffin S; Zou C; Little A; Astley H; Xia M
    Oncotarget; 2016 Feb; 7(7):8172-83. PubMed ID: 26882567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.